For many people, the challenge is not knowing that exercise matters. The challenge is keeping up with it when life, pain, injury, fatigue, changing hormones, travel, or age make the old routine harder to maintain.
That is why SLU-PP-332 is creating interest in performance, metabolic health, and healthy aging. This emerging compound is designed to support some of the same energy-related pathways muscles use during aerobic exercise.
In plain English: it is being explored for its potential to help the body use fuel more efficiently, support endurance-focused muscle activity, and complement a broader plan for staying strong and active.
Why People Are Paying Attention
Exercise changes how the body uses energy. It helps muscles become more efficient, supports stamina, and plays an important role in body composition and long-term metabolic health.
SLU-PP-332 is drawing attention because it targets some of those same internal muscle-and-energy signals. Rather than focusing primarily on appetite, the conversation is about how the body uses the energy that is already available.
That makes it especially interesting for people who want support beyond the usual “eat less and move more” message.
What This Could Mean for Your Goals
Support for muscle as your body changes
Maintaining muscle can become harder during perimenopause, after weight loss, through periods of stress or inactivity, and as we move through midlife and beyond. Muscle affects strength, mobility, energy, confidence, and how capable you feel in daily life.
SLU-PP-332 is of interest because of its connection to endurance-oriented muscle activity and energy use. For the right person, that may be a valuable part of a larger plan focused on staying strong and capable.
A more complete conversation about body composition
Body composition is more nuanced than the number on a scale. Appetite, protein intake, sleep, hormones, stress, movement, and the way your body uses fuel all matter.
For clients using medical weight management, the goal is often not simply to lose weight. It is to feel energized, preserve lean muscle, and create a result that is sustainable. SLU-PP-332 brings an additional muscle-and-energy perspective to that conversation.
An option worth discussing when workouts are not consistent
Some people love exercise but cannot always do it consistently. Others are rebuilding after injury, managing fatigue, working around pain, or navigating a demanding season of life.
SLU-PP-332 is not about giving up on movement. It is about exploring ways to support the body when a full workout routine is not always realistic.
More support for performance and healthy aging
Many active adults reach a point where their recovery feels slower, their stamina changes, or maintaining lean muscle requires more effort than it once did. They are not looking for a shortcut. They want a thoughtful plan that supports how they feel, train, and age.
That is where the conversation around SLU-PP-332 becomes especially compelling: it connects muscle health, energy use, and long-term function in one emerging area of care.
Who May Want to Learn More?
- Women in perimenopause or menopause who are noticing changes in energy, body composition, or muscle maintenance
- Active adults in midlife who want to maintain strength, stamina, and recovery
- Clients using medical weight management who want to keep muscle health part of the conversation
- People returning to activity after injury, illness, or an extended inactive period
- Adults focused on staying mobile, independent, and physically capable as they age
How It Fits Into the iRevive Approach
No single treatment replaces the basics of good care. Your goals, symptoms, health history, lab work, current medications, nutrition, sleep, and ability to train all help shape the right plan.
At iRevive, we look at the full picture. That may include comprehensive lab analysis, medical weight management, hormone optimization, nutrition guidance, movement, recovery, and carefully selected therapies that align with your goals.
SLU-PP-332 is one of the newer conversations in performance and metabolic medicine. If you want to explore whether a muscle- and energy-focused approach could fit your goals, schedule a consultation with iRevive.
What We Know So Far
The research behind SLU-PP-332 is still developing. Early laboratory and preclinical work has made researchers interested in its relationship to endurance-focused muscle activity, fuel use, body composition, and insulin response. Human outcomes continue to be an important area for future research.
Frequently Asked Questions
Is SLU-PP-332 a peptide?
SLU-PP-332 is a synthetic small molecule. It is often discussed alongside peptides because of the growing interest in muscle, energy, performance, and healthy-aging support.
What is SLU-PP-332 designed to support?
SLU-PP-332 is being explored for its connection to energy use, endurance-oriented muscle activity, body composition, and metabolic health. Your clinician can help determine whether it is appropriate to discuss in the context of your individual goals.
Can SLU-PP-332 be part of a weight-management plan?
Weight management is about much more than appetite. For clients who are focused on preserving muscle, supporting energy, and improving body composition, SLU-PP-332 may be a relevant topic to discuss as part of a personalized plan.
Is SLU-PP-332 for people who already exercise?
It may be of interest to active adults who want to support endurance, muscle maintenance, and recovery, as well as people whose ability to exercise is inconsistent because of pain, injury, fatigue, or life demands.
Medical note: SLU-PP-332 is an investigational compound. This article is educational and is not medical advice. A qualified clinician should review your individual health history, goals, medications, and treatment options.
References
- Billon C, et al. “Synthetic ERRα/β/γ Agonist Induces an ERRα-Dependent Acute Aerobic Exercise Response and Enhances Exercise Capacity.” ACS Chemical Biology, 2023. https://doi.org/10.1021/acschembio.2c00720
- Billon C, et al. “A Synthetic ERR Agonist Alleviates Metabolic Syndrome.” Journal of Pharmacology and Experimental Therapeutics, 2024. https://doi.org/10.1124/jpet.123.001733
- Xu W, et al. “Novel Pan-ERR Agonists Ameliorate Heart Failure Through Enhancing Cardiac Fatty Acid Metabolism and Mitochondrial Function.” Circulation, 2024. https://doi.org/10.1161/CIRCULATIONAHA.123.066542
- Wang XX, et al. “Estrogen-Related Receptor Agonism Reverses Mitochondrial Dysfunction and Inflammation in the Aging Kidney.” American Journal of Pathology, 2023. https://doi.org/10.1016/j.ajpath.2023.07.008
- Bonanni R, et al. “Targeting ERRs to Counteract Age-Related Muscle Atrophy Associated with Physical Inactivity: A Pilot Study.” Frontiers in Endocrinology, 2025. https://pubmed.ncbi.nlm.nih.gov/40692696/
- Okda HE, et al. “Chemical Optimization of the Exercise Mimetic SLU-PP-332 Enables Insight into Estrogen-Related Receptor Signaling.” International Journal of Biological Macromolecules, 2026. https://doi.org/10.1016/j.ijbiomac.2026.151450
